Medical Education Library

Highlights From the 2016 ECTRIMS Meeting

Neurology Reviews. 2016;24(suppl 9):S1-S12.

Selected highlights from the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis, which was held in London.


 

Click here to download the digital edition.

Neurology Reviews ®

Recommended Reading

Can Neurologists Predict Long-Term Disability Trajectories in Primary Progressive MS?
MDedge Neurology
Does the EDSS Capture Cognitive Difficulties in Patients With MS?
MDedge Neurology
Durable Efficacy of Alemtuzumab: Five-Year Follow-Up of the CARE-MS Studies
MDedge Neurology
Arbaclofen Extended-Release Tablets Are Effective for MS Spasticity
MDedge Neurology
Ocrelizumab Increases Likelihood of No Evidence of Disease Progression
MDedge Neurology
European guidelines cover entire spectrum of MS treatment
MDedge Neurology
Siponimod curbs disability in secondary progressive multiple sclerosis
MDedge Neurology
Alemtuzumab, natalizumab found equally effective for relapsing-remitting MS
MDedge Neurology
What Distinguishes MS From Its Mimics?
MDedge Neurology
Mobility benefits of MS drug dalfampridine confirmed by patient-reported outcomes
MDedge Neurology